AUPH Aurinia Pharmaceuticals Inc. Stock Quote

AUPH [NASD]

Index	-	P/E	-	EPS (ttm)	-1.41	Insider Own	9.77%	Shs Outstand	126.25M	Perf Week	2.77%
Market Cap	1.88B	Forward P/E	-	EPS next Y	-0.55	Insider Trans	0.00%	Shs Float	111.12M	Perf Month	10.07%
Income	-	PEG	-	EPS next Q	-0.14	Inst Own	55.87%	Short Float	4.61%	Perf Quarter	-1.07%
Sales	0.12M	P/S	16035.08	EPS this Y	-53.00%	Inst Trans	-	Short Ratio	2.29	Perf Half Y	6.52%
Book/sh	3.15	P/B	4.71	EPS next Y	45.50%	ROA	-	Target Price	11.50	Perf Year	-21.91%
Cash/sh	-	P/C	-	EPS next 5Y	-	ROE	-	52W Range	9.83 - 20.48	Perf YTD	7.45%
Dividend	-	P/FCF	-	EPS past 5Y	-	ROI	-	52W High	-27.44%	Beta	-
Dividend %	-	Quick Ratio	-	Sales past 5Y	-	Gross Margin	-	52W Low	51.17%	ATR	0.86
Employees	62	Current Ratio	-	Sales Q/Q	-87.40%	Oper. Margin	-	RSI (14)	56.84	Volatility	7.72% 5.35%
Optionable	Yes	Debt/Eq	-	EPS Q/Q	-	Profit Margin	-	Rel Volume	3.58	Prev Close	15.19
Shortable	Yes	LT Debt/Eq	-	Earnings	-	Payout	-	Avg Volume	2.23M	Price	14.86
Recom	1.70	SMA20	7.48%	SMA50	6.02%	SMA200	-0.58%	Volume	7,997,313	Change	-2.17%

Nov-03-20

Reiterated

H.C. Wainwright

Buy

$34 → $28

Jun-17-20

Initiated

BTIG Research

Buy

$20

May-05-20

Initiated

Cowen

Outperform

Jan-10-20

Initiated

Jefferies

Buy

$27

Dec-16-19

Reiterated

H.C. Wainwright

Buy

$25 → $32

Mar-16-18

Reiterated

Cantor Fitzgerald

Overweight

$14 → $16

Feb-08-18

Initiated

RBC Capital Mkts

Outperform

Oct-30-17

Reiterated

H.C. Wainwright

Buy

$10 → $12

May-18-17

Reiterated

H.C. Wainwright

Buy

$12 → $10

Apr-11-17

Initiated

Cantor Fitzgerald

Overweight

$14

Mar-22-17

Reiterated

FBR & Co.

Outperform

$9 → $11

Dec-30-16

Reiterated

H.C. Wainwright

Buy

$10 → $8

Aug-17-16

Reiterated

H.C. Wainwright

Buy

$7 → $10

Jun-30-16

Initiated

H.C. Wainwright

Buy

May-08-15

Initiated

MLV & Co

Buy

Jan-22-21 08:24PM	FDA Approves Aurinia Pharmaceuticals LUPKYNIS (voclosporin) for Adult Patients with Active Lupus Nephritis Business Wire
Jan-11-21 09:56AM	Implied Volatility Surging for Aurinia Pharmaceuticals (AUPH) Stock Options Zacks +5.37%
Jan-08-21 06:05AM	Aurinia Pharmaceuticals to Present at Two Upcoming Virtual Healthcare Conferences Business Wire
Jan-02-21 10:45AM	Attention Biotech Investors: Mark Your Calendar For January PDUFA Dates Benzinga
Dec-30-20 11:08AM	My Top Six 2020 Stock Picks Gained an Average of 75% TheStreet.com
Dec-28-20 08:32AM	Aurinia (AUPH) Looks Good: Stock Adds 5.5% in Session Zacks
Dec-21-20 03:40PM	Is AUPH A Good Stock To Buy According To Hedge Funds? Insider Monkey
Dec-17-20 11:02AM	Adding to an Old Favorite and Taking Some Profits in Cannabis TheStreet.com -14.70%
08:10AM	The Daily Biotech Pulse: MacroGenics Breast Cancer Drug Wins FDA Approval, Adcom Test Awaits Moderna, Virios To Make Wall Street Debut Benzinga
04:00AM	Aurinia Announces Collaboration and Licensing Agreement with Otsuka Pharmaceutical Co., Ltd. for the Development and Commercialization of Voclosporin in Europe and Japan Business Wire
Dec-16-20 07:15AM	The Daily Biotech Pulse: Novartis Gets Adcom Backing, Sio Gene Data, 2 IPOs, BioNTech Clinches China Vaccine Supply Deal Benzinga
Dec-15-20 05:59PM	Aurinia and Lonza Announce Exclusive Agreement for Dedicated Voclosporin Manufacturing Capacity Business Wire
03:00AM	Here's What Aurinia Pharmaceuticals Inc.'s (TSE:AUP) Shareholder Ownership Structure Looks Like Simply Wall St.
Dec-02-20 06:05AM	Aurinia Pharmaceuticals to Present at the Piper Sandler 32nd Annual Virtual Healthcare Conference Business Wire
Nov-29-20 06:44AM	Top 10 Healthcare Stocks To Buy for the Future Insider Monkey
Nov-20-20 05:00PM	Aurinia Announces New Employment Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) Business Wire +7.29%
Nov-12-20 04:05PM	Aurinia Pharmaceuticals to Present at the 2020 Jefferies Virtual London Healthcare Conference Business Wire
Nov-11-20 08:45AM	Should You Buy Aurinia Pharmaceuticals (AUPH) Ahead of Earnings? Zacks
Nov-10-20 05:15PM	Aurinia Pharmaceuticals (AUPH) Reports Q3 Loss, Lags Revenue Estimates Zacks
04:30PM	Aurinia Pharmaceuticals: Q3 Earnings Insights Benzinga
04:02PM	Aurinia Reports Third Quarter 2020 Financial Results and Recent Operational Highlights Business Wire
Nov-09-20 04:05PM	Aurinia Presents Integrated Time to Renal Response Data from the AURA-LV and AURORA Trials, along with Voclosporin Drug-Drug Interaction Data at ACR Convergence 2020 Business Wire
Nov-05-20 12:30PM	Aurinia Pharmaceuticals (AUPH) Expected to Beat Earnings Estimates: Can the Stock Move Higher? Zacks
Nov-04-20 02:25PM	Biotech Stock Roundup: Gilead, Amgen, Vertex and Alexion Report Q3 Earnings & More Zacks
Nov-03-20 07:38AM	The Daily Biotech Pulse: Aurinia Pulls The Plug On Dry Eye Disease Study, Karyopharm's Positive Readout, Emergency Use Authorization For OraSure Benzinga -9.87%
01:55AM	Aurinia Tanks 10% As Dry Eye Trial Fails To Reach Primary Endpoint SmarterAnalyst
Nov-02-20 04:05PM	Aurinia Announces Outcome of AUDREY Clinical Trial in Dry Eye Syndrome Business Wire
Oct-28-20 07:41AM	The Daily Biotech Pulse: Sanofi-GlaxoSmithKline To Supply 200M Doses To COVID-19 Vaccine Alliance, Gilead Earnings, Biodesix Debuts Benzinga
Oct-27-20 04:05PM	Aurinia Announces European Investigator-Initiated Trial to Evaluate Antiviral Activity of Voclosporin in Kidney Transplant Recipients with COVID-19 Business Wire
Oct-22-20 04:15PM	Aurinia Presents Voclosporin Efficacy and Pharmacokinetic Data from Integrated Analysis of AURA-LV and AURORA Pivotal Trials at ASN Kidney Week 2020 Business Wire
Oct-16-20 06:28AM	Analysts Expect Breakeven For Aurinia Pharmaceuticals Inc. (TSE:AUP) Before Long Simply Wall St.
Oct-14-20 06:05AM	Aurinia Pharmaceuticals Announces Launch of Lupus Nephritis Disease-State Awareness Initiative for Healthcare Professionals, TimeIsNephrons.com Business Wire
Oct-05-20 01:30PM	Shark Bites: Positioning for a Positive Catalyst in Aurinia Pharmaceuticals TheStreet.com +6.84%
Oct-02-20 05:00PM	Aurinia Announces New Employment Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) Business Wire
Sep-29-20 06:44PM	Aurinia Completes Final Patient Treatment in Dry Eye Study Zacks
Sep-28-20 06:05AM	Aurinia Completes Final Patient Treatment in AUDREY Phase 2/3 Clinical Trial of Voclosporin Ophthalmic Solution for Dry Eye Syndrome Business Wire
Sep-16-20 03:26PM	Hedge Funds Cant Stop Buying Aurinia Pharmaceuticals Inc (AUPH) Insider Monkey
Sep-10-20 06:05AM	Aurinia Pharmaceuticals to Present at Three Upcoming Virtual Investor Conferences Business Wire
Sep-04-20 06:04PM	Aurinia Announces New Employment Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) Business Wire
Aug-11-20 05:29PM	Recap: Aurinia Pharmaceuticals Q2 Earnings Benzinga
05:15PM	Aurinia Pharmaceuticals (AUPH) Reports Q2 Loss, Lags Revenue Estimates Zacks
04:02PM	Aurinia Reports Second Quarter 2020 Financial Results and Recent Operational Highlights Business Wire
Aug-04-20 12:30PM	Analysts Estimate Aurinia Pharmaceuticals (AUPH) to Report a Decline in Earnings: What to Look Out for Zacks
06:05AM	Aurinia Pharmaceuticals to Present at the BTIG Virtual Biotechnology Conference Business Wire
Jul-30-20 06:05AM	Aurinia Pharmaceuticals to Report Second Quarter 2020 Financial Results on August 11, 2020 Business Wire
Jul-28-20 12:33PM	Analysts Estimate Aurinia Pharmaceuticals (AUPH) to Report a Decline in Earnings: What to Look Out for Zacks
Jul-27-20 10:15AM	Aurinia Closes US$200 Million Public Offering of Common Shares Business Wire
Jul-23-20 06:59PM	Why Aurinia Pharmaceuticals Dived by 16% on Thursday Motley Fool -16.27%
Jul-22-20 11:05PM	Aurinia Prices US$200 Million Public Offering of Common Shares Business Wire +15.06%
04:08PM	Aurinia Announces Public Offering of Common Shares Business Wire
11:31AM	Why Aurinia Pharmaceuticals Is Up Today Motley Fool
07:24AM	The Daily Biotech Pulse: Aurinia's Kidney Inflammation Drug Filing Accepted For Review, Intuitive Surgical's Q2 Beat Benzinga
04:03AM	Aurinia Pharma Surges 9% On Priority Review For Lupus Kidney Treatment SmarterAnalyst
Jul-21-20 05:27PM	Aurinia Announces U.S. Food and Drug Administration Acceptance of the Filing of New Drug Application and Priority Review for Voclosporin for the Treatment of Lupus Nephritis Business Wire
Jul-18-20 10:02AM	Aurinia Pharmaceuticals (TSE:AUP) Is In A Good Position To Deliver On Growth Plans Simply Wall St.
Jul-15-20 01:15PM	Steven Cohen Homes in on Otonomy GuruFocus.com
Jul-12-20 08:15PM	Did Hedge Funds Make The Right Call On Aurinia Pharmaceuticals Inc (AUPH) ? Insider Monkey
Jun-22-20 06:05AM	Aurinia Completes Patient Enrollment Into the AUDREY Phase 2/3 Clinical Trial of Voclosporin Ophthalmic Solution for the Treatment of Dry Eye Syndrome Business Wire
Jun-09-20 10:20AM	Is Aurinia Pharmaceuticals Stock a Buy? Motley Fool
06:05AM	Aurinia Presents Additional AURORA Pivotal Trial Safety Data at the ERA-EDTA Virtual Congress 2020 Business Wire
Jun-08-20 03:00AM	Hedge Funds Keep Buying Aurinia Pharmaceuticals Inc (AUPH) Insider Monkey
Jun-05-20 07:05AM	Aurinia Presents AURORA Pivotal Trial Subgroup Analysis at the EULAR 2020 E-Congress Business Wire
Jun-04-20 06:34AM	Biotech Stocks: Buy This, Not That Motley Fool
Jun-03-20 06:05AM	Aurinia Announces Results of Annual General Meeting Business Wire
Jun-01-20 04:05PM	Aurinia Pharmaceuticals to Present at the Jefferies Virtual Healthcare Conference Business Wire
May-26-20 08:16AM	Aurinia Submits FDA New Drug Admission For Novel Voclosporin Kidney Treatment SmarterAnalyst
06:05AM	Aurinia Completes Submission of New Drug Application to the U.S. Food & Drug Administration for Voclosporin for the Treatment of Lupus Nephritis Business Wire
May-20-20 10:04AM	Billionaire Jim Simons Pulls the Trigger on These 3 Healthcare Stocks TipRanks
May-19-20 04:26PM	Aurinia Pharmaceuticals Inc (AUPH) Q1 2020 Earnings Call Transcript Motley Fool
06:10AM	Aurinia Pharmaceuticals Inc. (TSE:AUP) Released Earnings Last Week And Analysts Lifted Their Price Target To US$32.00 Simply Wall St.
May-15-20 04:05PM	Aurinia Pharmaceuticals to Present at 2020 RBC Capital Markets Virtual Global Healthcare Conference Business Wire
May-14-20 05:35PM	Aurinia Pharmaceuticals (AUPH) Reports Q1 Loss, Misses Revenue Estimates Zacks
04:02PM	Aurinia Reports First Quarter 2020 Financial Results and Recent Operational Highlights Business Wire
May-07-20 06:05AM	Aurinia Pharmaceuticals to Release First Quarter 2020 Financial Results on May 14, 2020 Business Wire
May-05-20 12:30PM	Analysts Estimate Aurinia Pharmaceuticals (AUPH) to Report a Decline in Earnings: What to Look Out for Zacks
Apr-29-20 01:12PM	Ken Fisher's Top 5 1st-Quarter Buys GuruFocus.com
Apr-27-20 06:05AM	Aurinia Appoints Joe Miller as Chief Financial Officer Business Wire
Apr-21-20 07:33AM	One Thing To Remember About The Aurinia Pharmaceuticals Inc. (TSE:AUP) Share Price Simply Wall St.
Apr-20-20 06:05AM	Aurinia Appoints Industry Veteran Timothy P. Walbert to its Board of Directors Business Wire
Apr-08-20 07:32PM	Hedge Funds Have Never Been This Bullish On Aurinia Pharmaceuticals Inc (AUPH) Insider Monkey
Mar-18-20 06:05AM	Aurinia Announces AURORA Phase 3 Clinical Data for Voclosporin in Lupus Nephritis to be Presented at National Kidney Foundation 2020 Spring Clinical Meetings Business Wire
Mar-17-20 06:00AM	Aurinia Pharmaceuticals Establishes U.S. Commercial Operations Center in Rockville, Maryland Business Wire
Mar-16-20 06:05AM	Aurinia Pharmaceuticals Initiates Rolling Submission of a New Drug Application to the U.S. Food and Drug Administration for Voclosporin in the Treatment of Lupus Nephritis Business Wire -10.23%
Mar-12-20 07:00AM	Aurinia Launches Resource Kit for People Living With Lupus Nephritis and Partners With National Kidney Foundation on Awareness Initiative Business Wire -9.01%
Mar-05-20 04:02PM	Aurinia Reports Fourth Quarter and Full Year 2019 Financial Results and Operational Highlights Business Wire
02:30PM	Aurinia Pharmaceuticals, Inc. to Host Earnings Call ACCESSWIRE
Mar-04-20 08:36AM	Do Options Traders Know Something About Aurinia (AUPH) Stock We Don't? Zacks
Mar-03-20 06:30AM	Aurinia Pharmaceuticals to Release Fourth Quarter and Full Year 2019 Financial Results on March 5, 2020 Business Wire
Feb-25-20 06:30AM	Aurinia Appoints Max Colao as Chief Commercial Officer and Expands U.S. Commercial Leadership Team Business Wire -6.18%
Feb-21-20 04:05PM	Aurinia Pharmaceuticals to Present at the 9th Annual SVB Leerink Global Healthcare Conference Business Wire
Feb-04-20 10:20AM	3 Strong Buy Small-Cap Stocks with Towering Growth Prospects TipRanks
Jan-23-20 09:11AM	Options Traders Expect Huge Moves in Aurinia Pharmaceuticals (AUPH) Stock Zacks
Jan-21-20 05:01AM	Do Directors Own Aurinia Pharmaceuticals Inc. (TSE:AUP) Shares? Simply Wall St.
Jan-02-20 07:00AM	My Top Stock Pick for 2020 Is a Super Strong Finisher From 2019 TheStreet.com +5.92%
Dec-13-19 10:29AM	Hedge Funds Have Never Been More Bullish On Aurinia Pharmaceuticals Inc (AUPH) Insider Monkey
Dec-12-19 09:26AM	Aurinia Closes US$191.7 Million Public Offering of Common Shares and Full Exercise of Underwriters Option to Purchase Additional Common Shares Business Wire
Dec-10-19 04:16PM	Why Biotech ETFs are Surging to New Highs Zacks +12.17%
Dec-09-19 09:00PM	Aurinia Prices US$166.7 Million Public Offering of Common Shares Business Wire
06:01AM	Aurinia Announces Public Offering of Common Shares Business Wire
Dec-07-19 08:35AM	The Week Ahead In Biotech: ASH Presentations Pick Up Steam, Correvio Awaits Adcom Ruling Benzinga

Aurinia Pharmaceuticals Inc., a clinical stage biopharmaceutical company, develops and commercializes therapies to treat various diseases in the United States and China. It is involved in developing voclosporin, an investigational drug for the treatment of lupus nephritis, dry eye syndrome, and focal segmental glomerulosclerosis. The company is headquartered in Victoria, Canada.

open in yahoo | open in reuters | open in google

Upgrade your FINVIZ experience